Where I see patients (1)
My reviews
5.0
Selected research
-
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
Neuro-oncology
-
Pre-surgery immune profiles of adult glioma patients.
Journal of neuro-oncology
-
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
Clinical trials
Feasibility of Individualized Therapy for Recurrent GBM
Feasibility of implementing a truly personalized tumor treatment drug regimen for patients with surgically resectable recurrent glioblastoma is defined as the percentage of patients who have successfully initiated therapy based on...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2966